Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis

Journal of Neuroimmunology

Volumn 86, Issue 1, 1998, Pages 13-19

  He, Bing ^a   Xu, Chun ^a   Yang, Bei ^a   Landtblom, Anne Marie ^a   Fredrikson, Sten ^a   Hillert, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Candidate genes; Cytokines; Linkage; Multiple selerosis; Myelin proteins

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN PROTEIN; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL DISEASE; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SWEDEN;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CASE-CONTROL STUDIES; CYTOKINES; FAMILY HEALTH; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LINKAGE (GENETICS); MULTIPLE SCLEROSIS; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-4; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032100761     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00003-4     Document Type: Article

References (30)

1. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J. Neuroimmunol. 54:1994;1-17.
2. The Canadian Collaboration Group, Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Nature. 377:1995;150-151.
3. Ebers G.C., Kukay K., Bulman D.E.et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
4. Goldin L.R., Weeks D.E. Two-locus models of disease: comparison of likelihood and nonparametric linkage methods. Am. J. Hum. Genet. 53:1993;908-915.
5. Graham C.A., Kirk C.W., Nevin N.C., Droogan A.G., Hawkins S.A., McMillan S.A., McNeil T.A. Lack of association between myelin basic protein gene microsatellite and multiple sclerosis. Lancet. 341:1993;1596.
6. He B., Navikas V., Lundahl J., Söderström M., Hillert J. Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63:1995;143-147.
7. Hugot J.-P., Laurent-Puig P., Gower-Rousseau C.et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 379:1996;821-823.
8. Link J., Fredrikson S., Söderström M., Olsson T., Höjeberg B., Ljungdahl Å., Link H. Organic-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann. Neurol. 35:1994;197-203.
9. Mikol D.D., Gulcher J.R., Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell. Biol. 110:1990;471-479.
10. Möller J.R., Johnson D., Brady R.O., Tourtellotte W.W., Quarles R.H. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis. J. Neuroimmunol. 22:1989;55-61.
11. Monoh K., Kurihara T., Takahashi Y., Ichikawa T., Kumanishi T., Hayashi S., Minoshima S., Shimizu N. Structure, expression and chromosomal localization of the gene encoding human 2′,3′-cyclic-nucleotide 3′-phosphodiesterase. Gene. 129:1993;297-301.
12. Navikas V., Link J., Palasik W., Söderström M., Fredrikson S., Olsson T., Link H. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand. J. Immunol. 41:1995;171-178.
13. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
14. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
15. Olsson T., Wang W.-Z., Höjeberg B., Kostulas V., Jiang Y.-P., Andersson G., Ekre H.-P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ J. Clin. Invest. 86:1990;981-985.
16. Ott J. Computer-simulation methods in human linkage analysis. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4175-4178.
17. Ott, J., 1991. Analysis of Human Genetic Linkage. Johns Hopkins University Press, Baltimore.
18. Panitch H.S., Hirsch R.L., Schindler J., Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
19. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
20. Rose J., Gerken S., Lynch S., Pisani P., Varvil T., Otterud B., Leppert M. Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet. 341:1993;1179-1181.
21. Roth M.P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J. Neuroimmunol. 51:1994;93-99.
22. Roth M.P., Dolbois L., Borot N., Pontarotti P., Clanet M., Coppin H. Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. J. Neuroimmunol. 61:1995;117-122.
23. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
24. Sun J.-B., Olsson T., Wang W.-Z., Xiao B.-G., Kostulas V., Fredrikson S., Ekre H.-P., Link H. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1991;1461-1468.
25. The Multiple Sclerosis Genetics Group A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
26. Tienari P.J., Wikström J., Sajantila A., Palo J., Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet. 340:1992;987-991.
27. Warren K.G., Catz I., Johnson E., Mielke B. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann. Neurol. 35:1994;280-289.
28. Weeks D.E., Lange K. A multilocus extension of the affected-pedigree-method of linkage analysis. Am. J. Hum. Genet. 50:1992;859-868.
29. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesion: detection by non-radioactive in situ hybridization. Cytokine. 5:1993;583-588.
30. Xiao B.G., Linington C., Link H. Antibodies to myelin oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:1991;91-96.